SCHEMBL7984206

SCHEMBL7984206

CCc1nc2ncn(Cc3cccc(F)c3)c2c(=O)[nH]1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.46
ALDH1A1 P00352 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
KMT2A Q03164 1/20 0.45
HCAR2 Q8TDS4 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
PDE1A P54750 1/20 0.41
PDE1B Q01064 1/20 0.41
PDE1C Q14123 1/20 0.41
GRIN1 Q05586 1/20 0.41
GRIN2B Q13224 1/20 0.41
NPSR1 Q6W5P4 2/20 0.40
PKM P14618 1/20 0.40
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.40
MKNK1 Q9BUB5 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40
MAPT P10636 1/20 0.40
THRB P10828 1/20 0.40
KDM1A O60341 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988482 0.91 PDE1A (0.46) HPGDALDH1A1SMN1; SMN2KMT2AHCAR2
SCHEMBL7989507 0.88 HPGD (0.46) HPGDALDH1A1SMN1; SMN2KMT2AHCAR2
SCHEMBL7974255 0.88 HPGD (0.47) HPGDALDH1A1SMN1; SMN2KMT2AHCAR2
SCHEMBL7988531 0.87 ALDH1A1 (0.44) HPGDALDH1A1SMN1; SMN2KMT2AHCAR2
SCHEMBL7984753 0.87 SMN1; SMN2 (0.51) HPGDALDH1A1SMN1; SMN2KMT2AHCAR2
SCHEMBL7984524 0.86 HPGD (0.52) HPGDALDH1A1SMN1; SMN2KMT2AKDM4E
SCHEMBL7975251 0.86 SMN1; SMN2 (0.60) HPGDALDH1A1SMN1; SMN2KMT2ARXFP1
SCHEMBL7984496 0.85 HPGD (0.45) HPGDALDH1A1SMN1; SMN2KMT2ARXFP1
SCHEMBL7984510 0.85 GAA (0.53) HPGDALDH1A1SMN1; SMN2KMT2AHCAR2
SCHEMBL7985648 0.83 HPGD (0.47) HPGDALDH1A1SMN1; SMN2KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed